A Trial for the Treatment of Cardiac AL-Amyloidosis With the Green Tea Compound Epigallocatechin-3-gallate (TAME-AL)
Clinical trial NCT02015312 · COMPLETED
Trial details
- NCT number
- NCT02015312
- Sponsor
- Florian Michel
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2017-10-11
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.